Use of Sotatercept in France since Its Availability in June 2024: A Nationwide Study from the French Health Data System (SNDS).

Charifa N, Weill A, Zureik M, Botton J, Haddy N

Open source

DOI
10.1007/s40801-026-00579-1
Published
2026 Sep 14
Container
Drugs - real world outcomes
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40801-026-00579-1,
  title = {Use of Sotatercept in France since Its Availability in June 2024: A Nationwide Study from the French Health Data System (SNDS).},
  author = {Charifa N and Weill A and Zureik M and Botton J and Haddy N},
  year = {2026},
  journal = {Drugs - real world outcomes},
  doi = {10.1007/s40801-026-00579-1},
  url = {https://doi.org/10.1007/s40801-026-00579-1}
}

RIS

TY  - JOUR
TI  - Use of Sotatercept in France since Its Availability in June 2024: A Nationwide Study from the French Health Data System (SNDS).
AU  - Charifa N
AU  - Weill A
AU  - Zureik M
AU  - Botton J
AU  - Haddy N
PY  - 2026
JO  - Drugs - real world outcomes
DO  - 10.1007/s40801-026-00579-1
UR  - https://doi.org/10.1007/s40801-026-00579-1
ER  - 

APA

N, C., A, W., M, Z., J, B., & N, H. (2026). Use of Sotatercept in France since Its Availability in June 2024: A Nationwide Study from the French Health Data System (SNDS).. Drugs - real world outcomes. https://doi.org/10.1007/s40801-026-00579-1

Source records